Table 2.
Summary of pathological features.
| Features (n = 34) | n | % |
|---|---|---|
| Granuloma | ||
| + | 26 | 76 |
| − | 8 | 24 |
| Vasculitis | ||
| + | 3 | 9 |
| − | 31 | 91 |
| Neuritis | ||
| + | 22 | 65 |
| − | 12 | 35 |
| Necrosis | ||
| + | 2 | 6 |
| − | 32 | 94 |
| Inflammatory infiltrates | ||
| Lymphocyte | 15 | 44 |
| Foamy histiocyte | 5 | 15 |
| Neutrophil | 2 | 6 |
| Plasma cell | 7 | 20 |
| Acid-fast stain | ||
| + | 25 | 74 |
| − | 9 | 26 |
| S100 | ||
| + | 12 | 35 |
| Not performed | 22 | 65 |
| Giant cell | ||
| + | 2 | 6 |
| − | 32 | 94 |
| Mycobacterium leprae PCR | ||
| Not performed | 25 | 74 |
| + | 4 | 12 |
| − | 5 | 15 |
| Drug-resistant gene | ||
| folP1 (dapsone) | 1 | 3 |
| rpoB (rifampin) | 0 | 0 |
| gyrA (ofloxacin) | 0 | 0 |
+ refers to features that were present; − refers to features that were not present.